LPL Financial’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

LPL Financial’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,533	Closed	-$194K	–	5174
2024 Q1	$194K	Buy	+22,533	New	+$108K	﹤0.01%	4517

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

LPL Financial's TCON Position: Q2 2024 in Review

LPL Financial sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 22,533 shares — an estimated $194K sold.

LPL Financial first reported a position in TCON in Q1 2024 and held it in 1 quarter. The position peaked at $194K in Q1 2024. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

LPL Financial reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
LPL Financial sold 22,533 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $194K.
LPL Financial first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
LPL Financial's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $194K in Q1 2024.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on LPL Financial's 13F filing for Q2 2024, filed 7 Aug 2024.